Abstract
Chronic obstructive pulmonary disease (COPD) is a common respiratory disease in China. Pulmonary hypertension is an important complication of COPD. Right heart catheterization is gold standard of pulmonary hypertension' s diagnosis, but echocardiography applied more widely. There is currently lack of better-performing drugs to treat COPD-related pulmonary hypertension. The long-term oxygen therapy can delay progression of COPD-related pulmonary hypertension. Inhaled prostacyclin and statins are more effective. Soluble guanylate cyclase activator,inhalation of endothelin receptor antagonists and nitric oxide are promising treatment. Key words: Chronic obstructive pulmonary disease; Pulmonary hypertension; Prostacyclin; Endothelin receptor antagonist
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
